[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2009, Vol. 7 ›› Issue (5): 472-477.doi: 10.3736/jcim20090514

• Medical Statistice • Previous Articles     Next Articles

How to express quantitative data: Part four

Liang-ping Hua,Hui-gang Liub,Li-xin Taoa   

  1. a Consulting Center of Biomedical Statistics, Academy of Military Medical Sciences, Beijing 100850, China
    b College of Basic Medical Sciences, Capital University of Medical Sciences, Beijing 100069, China
  • Received:2009-03-20 Accepted:2009-04-05 Online:2009-05-20 Published:2009-05-15

Key words: Statistics, Medicine, Data analysis, Statistical, Experimental design, Quantitative data

"

DBD使用与否 CTX使用与否: 空斑形成细胞(×104
不用
不用 4.86±0.89 2.41±0.79
8.53±1.83 5.12±0.93

"

造热损伤模型与否 采用GSS治疗与否: GR结合活性(μmol/g)
不是
465.95±88.95 298.29±79.22
不是 590.90±77.15 649.48±115.85

"

药材种类 炮制类型: 凝血时间(s)
生品 炭品
绵马贯众 155.5±28.2 128.6±23.8
单芽狗脊贯众 158.2±27.0 124.3±29.5

"

UVA用否 补骨脂素浓度 (μg/mL) n 细胞凋亡率 (%) 线粒体膜电位
0 3 6.51±0.20 262.00±3.51
10 3 7.99±0.34 232.37±2.73
20 3 9.23±0.39 132.83±1.34
40 3 11.94±0.50 119.83±2.56
80 3 17.84±0.57 117.50±0.98
不用 0 3 1.18±0.24 377.93±5.46
10 3 1.41±0.11 310.90±5.73
20 3 1.47±0.05 193.46±9.81
40 3 1.52±0.12 144.00±3.70
80 3 2.73±0.04 122.23±8.94

"

香豆素成分 浓(μmol/L) n Papp AP→BL
(×10–5 cm/s)
Papp BL→AP
(×10–5 cm/s)
Papp AP→BL/
Papp BL→AP
在Caco-2细胞中
的蓄积率(%)
总回收率(%)
伞形花内酯 25 3 2.470±0.278 2.980±0.433 0.83 3.31±0.17 83.58±6.35
50 3 2.638±0.148 3.640±0.297 0.72 2.32±0.49 81.66±1.22
100 3 2.929±0.125 3.517±0.158 0.83 1.01±0.11 84.68±0.82
甲氧基欧芹素 25 3 1.553±0.331 0.975±0.125 1.59 30.05±0.01 52.30±0.01
50 3 1.385±0.116 0.898±0.122 1.54 36.64±0.41 55.95±3.06
100 3 0.955±0.237 0.819±0.152 1.17 41.75±1.02 55.99±0.38
二氢欧山芹素 25 3 0.630±0.107 0.719±0.078 0.88 56.89±2.53 59.27±4.65
50 3 0.497±0.045 0.425±0.029 1.17 55.96±2.09 53.58±3.19
100 3 0.657±0.016 0.384±0.058 1.71 48.86±2.89 46.57±4.12
二氢欧山芹醇乙酯 25 3 0.253±0.026 0.173±0.048 1.46 6.51±0.53 8.39±0.12
50 3 0.343±0.021 0.252±0.075 1.36 2.39±0.29 10.25±0.12
100 3 0.284±0.011 0.241±0.020 1.18 5.11±2.15 8.57±0.81
当归醇-A 25 3 1.976±0.065 1.577±0.177 1.25 5.93±0.59 86.89±0.69
50 3 1.639±0.088 0.968±0.030 1.69 3.74±0.36 71.06±2.61
100 3 0.980±0.092 1.065±0.018 0.92 2.37±0.11 74.21±0.63
当归醇-B 25 3 1.496±0.128 0.656±0.042 2.28 3.11±0.70 74.34±7.34
50 3 1.604±0.036 0.837±0.042 1.92 2.28±0.59 67.10±1.70
100 3 1.140±0.279 0.769±0.060 1.48 1.83±0.06 50.25±8.07

"

5-FU用否 ESB剂量 n 吞噬率(%) 吞噬指数
不用 0 10 38.52±3.16 0.73±0.04
10 41.32±3.05 0.79±0.05
10 47.46±3.55 0.93±0.06
0 10 22.47±2.12 0.49±0.03
10 32.35±2.53 0.71±0.06
10 40.12±3.68 0.89±0.05

"

处理组别 时间(d) n BUN (mmol/L) SCr (mmol/L) 24 h尿蛋白(mg)
模型组 7 6 4.57±0.57 24.33±2.73 5.81±2.30
14 6 5.48±0.20 41.33±5.47 12.74±3.55
21 6 6.18±0.72 68.00±17.11 12.64±4.77
依那普利组 7 6 5.12±0.30 31.83±11.25 4.45±1.09
14 6 5.58±0.44 55.50±26.85 11.02±3.48
21 6 10.90±1.00 49.00±31.48 6.06±1.53
地灵丹组 7 6 4.62±0.42 32.33±16.05 5.37±2.41
14 6 6.30±1.15 50.67±4.97 9.52±7.96
21 6 9.73±1.45 32.83±9.26 6.06±3.20

"

大黄苷元用否 BMSC移植与否 时间(d) n IgG Col Ⅳ MMP-9 TIMP-1
7 7 25.20±8.70 44.48±14.38 48.95±20.45 35.88±6.87
14 6 27.68±10.72 49.52±7.35 32.48±7.37 35.19±13.31
28 7 26.00±1.51 45.27±8.13 36.19±5.57 36.39±5.08
不是 7 7 20.92±8.74 40.86±5.19 48.56±12.79 46.25±11.13
14 7 21.40±4.22 45.24±4.92 51.90±24.38 24.91±3.70
28 6 32.32±8.98 39.18±7.48 42.22±8.89 30.64±5.01
不用 7 7 28.86±3.91 27.71±4.70 50.91±8.16 35.87±5.72
14 6 20.08±5.91 32.54±4.30 31.99±5.98 42.37±8.93
28 6 22.92±4.93 34.33±5.09 39.18±10.79 29.61±3.13
不是 7 7 34.87±6.14 23.56±3.44 62.65±7.39 20.47±4.75
14 6 49.70±11.49 15.79±2.46 64.43±9.37 18.44±2.19
28 6 53.00±7.57 15.59±1.83 82.76±13.24 16.84±2.00

"

PDTC用否 ROS用否 IL-6蛋白含量(ng/L)
PTF用否: 不用
290.58±10.56 351.81±10.47
不用 323.08±9.69 299.48±11.16
不用 232.16±10.51 251.27±11.44
不用 239.31±10.69 612.58±18.60

"

区组 抑菌直径(mm)
药物种类及剂量: A(L H) B(L H)
1 18.02 19.41 18.00 19.46
2 18.12 20.20 18.91 20.38
3 18.09 19.56 18.21 19.64
4 18.30 19.41 18.24 19.50
5 18.26 19.59 18.11 19.56
6 18.02 20.12 18.13 19.60
7 18.23 19.94 18.06 19.54

"

区组编号 HIF-1α蛋白表达 p-Akt蛋白表达
A1(B1 B2) A2(B1 B2) A1(B1 B2) A2(B1 B2)
1 4.84±1.96 5.63±1.32 10.23±4.41 66.32±15.5 13.32±4.03 17.17±4.45 14.00±4.55 19.22±4.67
2 4.94±1.89 5.24±1.60 10.33±4.51 65.53±16.0 13.42±5.12 17.28±4.50 14.20±4.43 19.23±4.77
3 4.76±1.92 5.78±1.30 10.03±4.21 67.45±15.8 13.52±6.08 18.32±4.60 14.30±4.50 19.43±4.50
4 4.89±1.86 5.56±1.70 10.46±4.31 66.52±15.6 12.92±3.98 19.56±4.49 14.18±4.39 19.37±4.32

"

随机区组编号 尿总酸度(单位)
A1(B1 B2) A2(B1 B2) A3(B1 B2)
1 33.6 33.0 33.0 28.5 31.4 30.7
2 37.1 30.5 29.5 31.8 28.3 28.2
3 34.1 33.3 29.2 29.9 28.9 28.4
4 34.6 34.4 30.7 28.3 28.6 30.6
[1] Yuan GH, Pang XJ, Ma HC . Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice[J]. J Chin Integr Med, 2008,6(1):83-88
袁国红, 庞晓静, 马鹤超 . 当归补血汤对荷瘤小鼠的影响及对环磷酰胺化疗的增效减毒作用[J]. 中西医结合学报, 2008,6(1):83-88
[2] Hu LP, Gao H . How to use one-way analysis of variance correctly[J]. J Chin Integr Med, 2008,6(3):316-319
胡良平, 高辉 . 如何正确运用单因素多水平设计定量资料方差分析[J]. 中西医结合学报, 2008,6(3):316-319
[3] Gao H, Hu LP, Guo J . How to correctly discriminate and process quantitative data with design of multi-way: part one[J]. J Chin Integr Med, 2008,6(6):650-653
高辉, 胡良平, 郭晋 . 如何正确识别和处理几种易混淆的多因素设计定量资料(一)[J]. 中西医结合学报, 2008,6(6):650-653
[4] Huang SL, Chen NN, Xiang Y, Zhang C, Zhang L, Zhang DJ . Effects of psoralen with long wave ultraviolet light on apoptosis and mitochondrial membrane potential in K562 cells[J]. J Chin Integr Med, 2008,6(12):1259-1262
黄世林, 陈楠楠, 向阳, 张晨, 张励, 张德杰 . 补骨脂素加长波紫外线光化学疗法对K562细胞凋亡及线粒体膜电位的影响[J]. 中西医结合学报, 2008,6(12):1259-1262
[5] Yang XW, Guo QM, Wang Y . Absorption and transport of 6 coumarins isolated from the roots of Angelica pubescens f. biserrata in human Caco-2 cell monolayer model[J]. J Chin Integr Med, 2008,6(4):392-398
杨秀伟, 郭庆梅, 王莹 . 独活中6种香豆素类成分在Caco-2细胞单层模型中的吸收转运研究[J]. 中西医结合学报, 2008,6(4):392-398
[6] Dai ZJ, Wang XJ, Ji ZZ, Li ZF, Tang W, Kang HF, Ma XB, Liu L . Scutellaria barbata extract enhances efficacy and reduces toxicity of chemotherapy in hepatoma H22-bearing mice[J]. J Chin Integr Med, 2008,6(7):720-724
代志军, 王西京, 纪宗正, 李宗芳, 汤薇, 康华峰, 马小斌, 刘蕾 . 半枝莲提取物对H22肝癌荷瘤小鼠化疗的增效减毒作用[J]. 中西医结合学报, 2008,6(7):720-724
[7] Huan HD, Zhang JH, Zheng SR, Meng WW, Zhang JL . Dilingdan Decoction prevents renal interstitial fibrosis in a rat model of unilateral ureteral obstruction[J]. J Chin Integr Med, 2008,6(5):493-497
宦红娣, 张景红, 郑士荣, 孟巍巍, 张军力 . 地灵丹汤对单侧输尿管梗阻大鼠模型肾间质纤维化的防治作用[J]. 中西医结合学报, 2008,6(5):493-497
[8] Li JS, Liu JX, Sun J, Zhao YW, Su J, Li N, Guo XY . Effects of rhubarb aglycone on matrix metalloproteinase in cerebral ischemic tissue in rats with bone marrow mesenchymal stem cell transplantation[J]. J Chin Integr Med, 2008,6(8):810-816
李建生, 刘敬霞, 孙捷, 赵跃武, 苏静, 李宁, 郭晓燕 . 大黄苷元对骨髓间充质干细胞移植脑缺血大鼠基质金属蛋白酶的影响[J]. 中西医结合学报, 2008,6(8):810-816
[9] Lou SY, Liu Y, Chen WH, Ying J, He YM, Wang WJ . Pollen Typhae total flavones inhibit expression of interleukin-6 in C2C12 skeletal muscle cells cultured with palmitate[J]. J Chin Integr Med, 2008,6(5):488-492
娄少颖, 刘毅, 陈伟华, 应健, 何燕铭, 王文健 . 蒲黄总黄酮抑制棕榈酸培养下C2C12骨骼肌细胞白细胞介素6的表达[J]. 中西医结合学报, 2008,6(5):488-492
[10] Zhang M, Xu ZY, Bai B, Dong Y . Feiyanning Decoction down-regulates the expressions of phosphorylated Akt and hypoxia inducible factor-1α proteins in transplanted lung adenocarcinoma in nude mice[J]. J Chin Integr Med, 2008,6(6):616-620
张铭, 徐振晔, 白冰, 董昀 . 肺岩宁方下调裸鼠人肺腺癌细胞移植瘤中磷酸化Akt和缺氧诱导因子1α蛋白表达[J]. 中西医结合学报, 2008,6(6):616-620
[11] Hu LP. Application of triple-type theory of statistics in statistical expression and description[M]. Beijing: People's Military Medical Press,2008: 104-105
胡良平 . 统计学三型理论在统计表达与描述中的应用[M]. 北京: 人民军医出版社,2008: 104-105
[1] Wei-Jun Zhang, Da-Ming Su , Ka-Kit Hui. The development and current status of integrative medicine at UCLA. Journal of Chinese Integrative Medicine, 2012, 10(9): 953-960.
[2] Liang-ping Hu, Xiao-lei Bao, Chen-long Lv. Two-factor designs unable to examine the interactions (Part 2). Journal of Chinese Integrative Medicine, 2012, 10(9): 966-969.
[3] Ming T. Tan , Jian-ping Liu , Lixing Lao. Adequate application of quantitative and qualitative statistic analytic methods in acupuncture clinical trials. Journal of Chinese Integrative Medicine, 2012, 10(8): 847-852.
[4] Fan Yin, Ziyi Fan. Dr. Wu: A beautiful, moving and meditative song — In memory of Dr. Jing Nuan Wu, a pioneer of acupuncture and a Chinese medicine doctor in the United States. Journal of Chinese Integrative Medicine, 2012, 10(8): 837-840.
[5] Liang-ping Hu, Xiao-lei Bao, Chen-yi Guo . Two-factor designs unable to examine the interactions (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(8): 853-857.
[6] Claudia Maria Sous, Mario Goncalves, Jorge Machado, Thomas Efferth, Tobias Greten , Petra Froeschen , Henry J. Greten. Effects of qigong on performance-related anxiety and physiological stress functions in transverse flute music schoolchildren: A feasibility study. Journal of Chinese Integrative Medicine, 2012, 10(8): 858-865.
[7] Liang-ping Hu , Xiao-lei Bao, Chen-long Lü . How to choose an appropriate experimental design type (Part 2). Journal of Chinese Integrative Medicine, 2012, 10(7): 738-742.
[8] David Sibbritt, Pamela van der Riet, Saowapa Dedkhard, Kannapatch Srithong. Rehabilitation of stroke patients using traditional Thai massage, herbal treatments and physical therapies. Journal of Chinese Integrative Medicine, 2012, 10(7): 743-750.
[9] C. Matos Luís, J. Goncalves Mário, R. Silva António, G. Mendes Joaquim, P. Machado Jorge, J. Greten Henry. Assessment of Qigong-related effects by infrared thermography: A case study. Journal of Chinese Integrative Medicine, 2012, 10(6): 663-666.
[10] Liang-ping Hu, Xiao-lei Bao. How to choose an appropriate experimental design type (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(6): 615-618.
[11] Qing-hui Zhou . Assessment of research papers in medical university staff evaluation. Journal of Chinese Integrative Medicine, 2012, 10(6): 707-711.
[12] Yathiraj Ashwini, Mohamed Rafiq, Gollapalle L. Viswanatha, Subbanna Rajesh, Selvam Senthilraja, Mohammed Azeemuddin, Suryakanth D. Anturlikar, Paramesh Rangesh, Pralhad S. Patki . Polyherbal formulation Bresol® protects the mast cells against compound 48/80-induced disruption and histamine release: A non-immunological mechanism of mast cell stabilization. Journal of Chinese Integrative Medicine, 2012, 10(6): 690-694.
[13] Liang-ping Hu, Xiao-lei Bao, Qi Wang . The balance principle in scientific research. Journal of Chinese Integrative Medicine, 2012, 10(5): 504-507.
[14] Fan Yin . The first acupuncture center in the United States: An interview with Dr. Yao Wu Lee, Washington Acupuncture Center. Journal of Chinese Integrative Medicine, 2012, 10(5): 481-492.
[15] Qin-hui Fu, Jian Pei, Qi Jia, Yi Song, Yue-hua Gu, Xiao-xin You . Acupuncture treatment programs for post-stroke motor rehabilitation in community hospitals: Study protocol of a multicenter, randomized, controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(5): 516-524.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[2] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[3] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[4] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[5] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[6] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92
[7] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[8] Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017
[9] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022
[10] Bing Hu , Hong-mei An , Ke-ping Shen , Qin Du. Senescence-inducing effects of Chinese herbal medicine Tenglong Buzhong Decoction on human colon carcinoma LS-174-T cells and the mechanism. Journal of Chinese Integrative Medicine, 2010, 8(11): 1048-1052
[an error occurred while processing this directive]